Profiel
Sandeep C.
Kulkarni was the Chief Operating Officer at Immunovant, Inc. in 2018 and 2019.
Eerdere bekende functies van Sandeep C. Kulkarni
| Bedrijven | Functie | Einde |
|---|---|---|
| IMMUNOVANT, INC. | Chief Operating Officer | 01-12-2019 |
Immunovant, Inc. /Old/
 Immunovant, Inc. /Old/ BiotechnologyHealth Technology Immunovant, Inc. is a biopharmaceutical company, which engages in the development of therapies for autoimmune diseases. It focuses on its product pipeline, IMVT-1401, which is a human recombinant anti-neonatal Fc receptor monoclonal antibody for the treatment of IgG mediated diseases. The company is headquartered in New York, NY. | Chief Operating Officer | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| IMMUNOVANT, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Immunovant, Inc. /Old/
Immunovant, Inc. /Old/ BiotechnologyHealth Technology Immunovant, Inc. is a biopharmaceutical company, which engages in the development of therapies for autoimmune diseases. It focuses on its product pipeline, IMVT-1401, which is a human recombinant anti-neonatal Fc receptor monoclonal antibody for the treatment of IgG mediated diseases. The company is headquartered in New York, NY. | Health Technology |
